pGS-scAAV-ITR141-Kan-eGFP
A GenScript-innovative self-complementary AAV (scAAV) transfer vector engineered with superior ITR stability and high plasmid yield. This vector includes a truncated AAV2 ITR sequence, a kanamycin resistance gene, GFP for real-time visualization of transgene delivery, a WPRE element for enhanced expression, and an SV40 polyadenylation signal. Ideal for proof-of-concept studies and preclinical validation.
| $1299.00 | |
| RP-B00039-10 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |